Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ZyGem Launches Microbial Fingerprinting Technology On Infectious Diseases
The approach is designed to run on ZyGem’s new MicroLab platform. The company claimed that the platform has the potential to accurately identify up to 30 types of
The approach is designed to run on ZyGem’s new MicroLab platform. The company claimed that the platform has the potential to accurately identify up to 30 types of
Cubist Pharma said that the increase was attributable primarily to its net sales of Cubicin (daptomycin for injection) in the US, which increased 23% to $155m from $126.1m
Novartis’ operating income rose 25% to $3bn, compared to $2.4bn for the comparable period in 2009. Earnings per share (EPS) increased 18% to $1.06 while core EPS was
AVI-6002 and AVI-6003 are RNA-based therapeutic candidates from AVI’s anti-infective portfolio and use its proprietary PMOplus chemistry. The current contract is funded as part of the Transformational Medical
GTC and Lundbeck said that ATryn is approved for the prevention of peri-operative and peri-partum thromboembolic events in patients with hereditary antithrombin deficiency (HD AT), a rare and
According to Apicore, the inspection was concluded successfully and it acts as a final milestone on the path to ANDA approval. Apicore said that following this milestone, Apicore
Alcon is expected to use Varicent for core commission calculation in addition to scenario modeling, providing enhanced visibility into Alcon’s current and future sales quotas. Varicent is expected
Emergent said that its Baltimore manufacturing facility could create an additional 120 jobs in the next five years. Emergent is currently working on modifying and re-commissioning the facility.
CSL said that the main aim of the project is to create Victoria’s first large scale biotechnology facility for the late stage development of new therapies for cancer,
PharmaHub is expected to represent the Sichuan government in seeking out biotechnology projects and the STEC will be helping PharmaHub and its partners in executing business ventures in